RecruitingPHASE1, PHASE2NCT05736406

A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

Studying Glioblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hemerion Therapeutics
Principal Investigator
Jan Drappatz, MD
UPMC Presbyterian Shadyside Hospital, Pittsburgh, PA
Intervention
5-ALA HCl intraoperative Photodynamic Therapy (PDT) at 200 J/cm^2(combination_product)
Enrollment
12 enrolled
Eligibility
18-75 years · All sexes
Timeline
2024 – 2026

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05736406 on ClinicalTrials.gov

Other trials for Glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Glioblastoma →

← Back to all trials